Clinical Trials Directory

Trials / Completed

CompletedNCT06898112

Mixed-methods Protocol for the WiSSPr Study

Mixed-methods Protocol for the WiSSPr Study: Women in Sex Work, Stigma and Psychosocial Barriers to Pre-exposure Prophylaxis in Zambia

Status
Completed
Phase
Study type
Observational
Enrollment
299 (actual)
Sponsor
Centre for Infectious Disease Research in Zambia · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

WiSSPr is a prospective observational cohort study grounded in community-based participatory research principles with a community advisory board (CAB) of key population (KP) civil society organi sations (KP-CSOs) and the Ministry of Health (MoH).

Detailed description

WiSSPr is a prospective observational cohort study grounded in community-based participatory research principles with a community advisory board (CAB) of key population (KP) civil society organi sations (KP-CSOs) and the Ministry of Health (MoH). We will administer a one-time psychosocial survey vetted by the CAB and follow 300 WESW in the electronic medical record for three months to measure PrEP initiation (#/% ever taking PrEP) and persistence (immediate discontinuation and a medication possession ratio). We will conduct in-depth interviews with a purposive sample of 18 women, including 12 WESW and 6 peer navigators who support routine HIV screening and PrEP delivery, in two community hubs serving KPs since October 2021. We seek to value KP communities as equal contributors to the knowledge production process by actively engaging KP-CSOs throughout the research process. Expected outcomes include quantitative measures of PrEP initiation and persistence among WESW, and qualitative insights into the enablers and barriers to PrEP use informed by participants' lived experiences. https://doi.org/10.1136/bmjopen-2023-080218

Conditions

Interventions

TypeNameDescription
DRUGPrEPoral PrEP

Timeline

Start date
2023-07-18
Primary completion
2024-03-31
Completion
2024-03-31
First posted
2025-03-27
Last updated
2025-03-27

Locations

1 site across 1 country: Zambia

Source: ClinicalTrials.gov record NCT06898112. Inclusion in this directory is not an endorsement.